Updated Jul 16, 2026
Kaushal Mohit is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $335K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-04-16 | TOI | Oncology Institute, Inc. | S — Open-market sale | 38.4K | $3.50 | $135K |
| 2026-04-16 | TOI | Oncology Institute, Inc. | S — Open-market sale | 57.3K | $3.50 | $201K |
| 2025-11-24 | TOI | Oncology Institute, Inc. | A — Grant or award | 40.1K | $0.00 | |
| 2025-11-24 | TOI | Oncology Institute, Inc. | A — Grant or award | 50.9K | $0.00 | |
| 2024-11-25 | TOI | Oncology Institute, Inc. | A — Grant or award | 56.0K | $0.00 |
Kaushal Mohit is a corporate insider — currently tracked as Director. InsiderAlpha tracks every SEC Form 4 filing in real time.
Recorded transactions: 0 open-market purchases () and 2 open-market sales ($335K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Kaushal Mohit profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.